-
Are Psychedelics Cannabis 2.0? Takeaways From The Top Psychedelics Business Conference In The US
Monday, May 15, 2023 - 2:27pm | 2117This article was originally published on Cannabis.net and appears here with permission. A funny thing happened on the way to Fort Lauderdale having Biblical flooding after the Benzinga Cannabis Capital Conference in Miami, with the airport closed for 48 hours, Cannabis.net got to stick around and...
-
EXCLUSIVE: Johns Hopkins Professor Says Psychedelic Medicine Could Get Messy, Calling For 'Right, Smart, Non-Restrictive, Yet Preventive' Regulations
Friday, April 21, 2023 - 12:23pm | 665Yetter Coleman’s Matt Zorn chatted with none other than multi-awarded and great psychedelics researcher Dr. Matthew Johnson at Benzinga’s recently held Psychedelics Capital Conference. Dr. Matthew W. Johnson, Ph.D., is a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins....
-
EXCLUSIVE: Making The World A Better Place, How Psychedelics Are Helping
Thursday, April 13, 2023 - 6:59pm | 679It's human nature to fear what we cannot understand. The best way to conquer that fear is with knowledge, Brock Pierce told the crowd at Benzinga Psychedelics Capital Conference on Thursday in Miami Beach. The crypto billionaire, economist and philanthropist who serves as...
-
EXCLUSIVE: Human Connection Is Essential Element For Healing With Psychedelics
Thursday, April 13, 2023 - 1:30pm | 686“We are not going to be walking into a dispensary and buying DMT or ayahuasca any time soon,” said Simeon Schnapper, managing partner JLS FUND at Benzinga Psychedelics Capital Conference Thursday in Miami Beach, Florida. Comparing the cannabis and psychedelics...
-
This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention
Wednesday, April 5, 2023 - 12:42pm | 371Psycheceutical Bioscience (OTC: BWVI), a company focused on developing innovative technologies for the next generation of mental health treatments, recently hosted Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), at one of its drug development...
-
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
Monday, April 3, 2023 - 2:05pm | 975The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. Scheduled for April 13th, this year's edition follows the well-established Cannabis Capital Conference (CCC) and will take...
-
Reggie Watts On Cannabis And Psychedelics: 'An Opportunity To Discover Something New About Myself'
Friday, March 31, 2023 - 9:39am | 1688Anyone who’s ever watched a live performance by Reggie Watts knows the man does not like to be pigeonholed. The actor, performer, comedian, musician and beatboxer is definitely one of a kind. Throughout his formative years, Watts immersed himself in cannabis and psychedelics-infused...
-
EXCLUSIVE: Berner Talks Psychedelics And The Importance Of Proper Dosing
Thursday, March 30, 2023 - 4:07pm | 478Berner, the rapper, co-founder and CEO of the cannabis and clothing brand Cookies, spoke at Benzinga's Psychedelics Capital Conference in Miami Beach in April 2022. During the conference, he talked about the genesis of Cookies and how it evolved into a multi-million dollar brand. He said that...
-
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Monday, April 25, 2022 - 5:55pm | 2582Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education. For those who weren't able to join us come...
-
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
Monday, April 25, 2022 - 5:46pm | 1193Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach on April 19 for a full day of networking and education. We’re happy to share a full...
-
EXCLUSIVE: Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury
Wednesday, April 20, 2022 - 7:59am | 486Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway. A former NHL star, Carcillo won two Stanley Cups before retiring at the age of 30 due to Post-Concussion Syndrome...
-
EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space
Tuesday, April 19, 2022 - 5:19pm | 405Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock. In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy. At the...
-
EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
Tuesday, April 19, 2022 - 4:47pm | 427Psyched Wellness Ltd (OTCQB: PSYCF) plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S. It’s derived from amanita muscaria, an instantly recognizable, red-capped fungi, and its active ingredient muscimol. “Everyone...
-
EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments
Tuesday, April 19, 2022 - 3:22pm | 842ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments. The company operates a decentralized hub and spoke model in which each of ATAI's platform companies focuses on one lead compound in a single...
-
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
Tuesday, April 19, 2022 - 2:24pm | 700If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you. The Toronto-based company is studying derivatives of psilocybin and DMT and plans to file an investigational new drug application with the FDA during this quarter, CEO Doug...